In the wake of current global financial crisis, Mumbai-based drugmaker Wockhardt is working out a new strategy to shore up sagging profit margins and stay ahead of the competition. According to sources, Wockhardt chairman Habil Khorakhiwala has decided to put Wockhardt's Irish business Pinewood Labs up for sale for $200 million.
